Short description
Neurotrack develops digital cognitive health screening solutions to reduce the risk of Alzheimer's and related dementias.
Description
Neurotrack is a digital health company on a mission to transform the diagnosis and management of Alzheimer's and other dementias. The company develops turnkey tools for providers that can be easily delivered at scale to facilitate early detection of cognitive impairment and ongoing monitoring of cognitive function. Neurotrack's patient-guided, clinically-validated cognitive assessments work in the clinic or at home to fit any workflow. Neurotrack has published 27 peer-reviewed papers, holds 11 patents on its proprietary technology, and is registered as an FDA Class II medical device. For more information visit neurotrack.com.
The company was founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola and is based in Redwood City, California.
Total funding
$$43214321
Sign in for full access
Location
Redwood City, California, United States, North America
Founded on
January 1, 2012
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Cannot Access, Absolutely Noaccess, Nopepepe, No Way, Blurry Noaccess, Noaccessforu, Noaccessforu, Noaccess, Cannot Access, Noaccess, Blurry Noaccess, Nopepepe, Nopepepe, Noaccessforu, Blurry Noaccess
Sign in for full access
Founders
Elizabeth Buffalo, Elli Kaplan, Vitalik Miniailo